scholarly journals Fatal tumor lysis syndrome in a patient with metastatic colon cancer after palliative chemotherapy

2013 ◽  
Vol 46 (6) ◽  
pp. 200-203 ◽  
Author(s):  
Ming-Hao Hsieh ◽  
Chou-Chan Chen ◽  
Miao-Lin Hu ◽  
Te-Cheng Yueh
Keyword(s):  
Colon Cancer ◽  
Palliative Chemotherapy ◽  
Tumor Lysis Syndrome ◽  
Metastatic Colon Cancer ◽  
Tumor Lysis

scholarly journals Fatal Spontaneous Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer: A Clinical Case of Rare Oncological Emergency

2020 ◽  
Vol 14 (2) ◽  
pp. 255-260
Author(s):  
Inna Shaforostova ◽  
Robert Fiedler ◽  
Martina Zander ◽  
Johannes Pflumm ◽  
Wolfgang Josef März
Keyword(s):  
Colon Cancer ◽  
Case Reports ◽  
Multiorgan Failure ◽  
Tumor Lysis Syndrome ◽  
Metastatic Colon Cancer ◽  
Tumor Lysis ◽  
Oncological Emergency ◽  
Electrolyte Disturbances ◽  
Life Threatening ◽  
Spontaneous Tumor Lysis Syndrome

Tumor lysis syndrome (TLS) is a potentially life-threatening complication of chemotherapy. It usually occurs in rapidly proliferating hematological malignancies. TLS is deemed spontaneous (STLS) when it occurs prior to any cytotoxic or definite treatment. STLS is extremely rare in solid tumors. Here, we report a rare case of fatal STLS in a 47-year-old woman diagnosed with metastatic colon cancer. The patient developed acute renal failure with anuria, electrolyte disturbances, and metabolic acidosis before initiating chemotherapy. Despite appropriate management of TLS, including renal replacement therapy, she died within a few days from multiorgan failure. Only few other case reports of STLS associated with colon cancer have been reported in the literature.

scholarly journals Tumor lysis syndrome in a patient with metastatic colon cancer after treatment with oxaliplatin and 5-Fu

2016 ◽  
Vol 3 (4) ◽  
pp. 124-127 ◽  
Author(s):  
Ruo-Han Tseng ◽  
Ching-Hsu Wu ◽  
Kuan-Lin Wu ◽  
Guan-Min Lai ◽  
Jen-Tsun Lin
Keyword(s):  
Colon Cancer ◽  
Tumor Lysis Syndrome ◽  
Metastatic Colon Cancer ◽  
Tumor Lysis

Rapid Tumor Lysis Syndrome in a Patient with Metastatic Colon Cancer as a Complication of Treatment with 5-Fluorouracil/Leucoverin and Irinotecan

2004 ◽  
Vol 90 (5) ◽  
pp. 514-516 ◽  
Author(s):  
Ilhan Oztop ◽  
Binnaz Demirkan ◽  
Arzu Yaren ◽  
Oktay Tarhan ◽  
Bulent Sengul ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Tumor Lysis Syndrome ◽  
Metastatic Colon Cancer ◽  
Tumor Lysis

scholarly journals Fatal tumor lysis syndrome after irinotecan/5-FU/folinic acid/bevacizumab-containing therapy in a patient heavily pretreated for metastatic colon cancer

2008 ◽  
Vol 47 (1) ◽  
pp. 155-156 ◽  
Author(s):  
Marcus Hentrich ◽  
Xaver Schiel ◽  
Birgit Scheidt ◽  
Michael Reitmeier ◽  
Ulrike Hoffmann ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Folinic Acid ◽  
Tumor Lysis Syndrome ◽  
Metastatic Colon Cancer ◽  
Tumor Lysis ◽  
Heavily Pretreated

Fatigue control in metastatic colon cancer treated with capecitabine and oxaliplatin.

2012 ◽  
Vol 30 (15_suppl) ◽  
pp. e19628-e19628
Author(s):  
Fernanda Maris Peria ◽  
Lilian Andrade Sá ◽  
Harley Francisco Oliveira ◽  
Josiane Cheli Vettori ◽  
Daniela Pretti da Cunha Tirapelli ◽  
...  
Keyword(s):  
Quality Of Life ◽  
Colon Cancer ◽  
Cancer Patients ◽  
Palliative Chemotherapy ◽  
Large Population ◽  
Concurrent Chemotherapy ◽  
Metastatic Colon Cancer ◽  
Chemotherapy Treatment ◽  
Chi Squared

e19628 Background: Fatigue is one of the most frequent symptoms in cancer patients, characterized by profound fatigue that is not relieved by rest. This symptom can be identified at the time of diagnosis and could affects up to 90% of patients undergoing cancer treatment. There are some instruments available in the literature that can characterize the presence of fatigue through clinical questioning. Methods: Considering the large population of patients with metastatic colorectal cancer treated with chemotherapy and the prevalence of fatigue in these patients, this study evaluated the presence of fatigue in 27 metastatic colon cancer patients before the first, second, third and fourth cycles of fist line palliative chemotherapy regimen containing CAPOX (capecitabine and oxaliplatin) by applying the evaluation questionnaire FACIT-F fatigue. Results: The results post Friedman chi-squared test demonstrated that there was no improvement of fatigue during these four cycles of CAPOX palliative chemotherapy (p=0,2574). The FACIT-G analysis demonstrated no worsening of quality of life (p=0,2411) during and between the four cycles of chemo. All different parameters included in FACIT-F questionnaires: emotional (p=0,2629), physical (p=0,3199), familiar (p=0,1456), functional (p=0,8662) and specific fatigue topic (p=0,7569) confirmed no difference between the cycles. Conclusions: Despite the metastatic stage of colon cancer patients and concurrent chemotherapy treatment, there was no fatigue improvement during the four first CAPOX chemo cycles courses and there was the maintenance of quality of life.

scholarly journals Spontaneous tumor lysis syndrome in colon cancer: a case report and literature review

2017 ◽  
Vol 5 (12) ◽  
pp. 2121-2126 ◽  
Author(s):  
David Sommerhalder ◽  
Amol M. Takalkar ◽  
Rodney Shackelford ◽  
Prakash Peddi
Keyword(s):  
Colon Cancer ◽  
Case Report ◽  
Literature Review ◽  
Tumor Lysis Syndrome ◽  
Tumor Lysis ◽  
Spontaneous Tumor ◽  
Spontaneous Tumor Lysis Syndrome

scholarly journals A Case of Tumor Lysis Syndrome Induced by Surgery in Colon Cancer with Multiple Liver Metastases

2019 ◽  
Vol 03 (06) ◽  
Author(s):  
Manabu Yamamoto ◽  
Norifumi Iseda ◽  
Hiroko Yano ◽  
Yohei Tominaga, ◽  
Ayako Sugino ◽  
...  
Keyword(s):  
Colon Cancer ◽  
Liver Metastases ◽  
Tumor Lysis Syndrome ◽  
Tumor Lysis ◽  
Multiple Liver Metastases
Sign in / Sign up

Export Citation Format

Share Document